Synthesis 2007(3): 367-374  
DOI: 10.1055/s-2006-958963
PAPER
© Georg Thieme Verlag Stuttgart · New York

Synthesis of 8-Substituted Pyrazolo[1,5-a]-1,3,5-triazine Derivatives by Palladium-Catalyzed Cross-Coupling Reactions

Florence Popowycza, Philippe Bernardb, Pierre Raboissonb, Benoît Joseph*a
a Laboratoire de Chimie Organique 1, UMR-CNRS 5181, Université Claude Bernard - Lyon 1, CPE - Bâtiment 308, 43 Boulevard du 11 Novembre 1918, 69622 Villeurbanne cedex, France
Fax: +33(4)72431214; e-Mail: benoit.joseph@univ-lyon1.fr;
b Greenpharma SA, 3 Allée du Titane, 45100 Orléans, France
Further Information

Publication History

Received 5 September 2006
Publication Date:
21 December 2006 (online)

Abstract

8-Substituted pyrazolo[1,5-a]-1,3,5-triazine derivatives 6 were prepared from the corresponding 8-iodopyrazolo[1,5-a]-1,3,5-triazines 5 through palladium-catalyzed cross-coupling reactions. Several bioisosteres of hypoxanthine drugs 2 were then prepared by final nucleophilic aromatic substitution.

    References

  • 1 Senga K. O’Brien DE. Scholten MB. Novinson T. Miller JP. Robins RK. J. Med. Chem.  1982,  25:  243 
  • 2a Gilligan PJ. Folmer BK. Hartz RA. Koch S. Nanda KK. Andreuski S. Fitzgerald L. Miller K. Marshall WJ. Bioorg. Med. Chem.  2003,  11:  4093 
  • 2b He L. Gilligan PJ. Zaczek R. Fitzgerald LW. McElroy J. Shen H.-SL. Saye JA. Kalin NH. Shelton S. Christ D. Trainor G. Hartig P. J. Med. Chem.  2000,  43:  449 
  • 3 Almansa C. de Arriba AF. Cavalcanti FL. Gómez LA. Miralles A. Merlos M. García-Rafanell J. Forn J. J. Med. Chem.  2001,  44:  350 
  • 4a Prevost G, Lonchampt M.-O, Kim S, Morgan B, Ulibarri G, and Thurieau C. inventors; PCT Int. Appl. WO  2002050079.  Chem. Abstr. 2002, 137, 47234
  • 4b Guzi TJ, and Paruch K. inventors; US Patent US  2005187219.  Chem. Abstr. 2005, 143, 248417
  • 5 Lübbers T. Angehrn P. Gmünder H. Herzig S. Kulhanek J. Bioorg. Med. Chem. Lett.  2000,  10:  821 
  • 6 Subramanyam C. Ault B. Sawutz D. Bacon ER. Singh B. Pennock PO. Kelly MD. Kraynak M. Krafte D. Treasurywala A. J. Med. Chem.  1995,  38:  587 
  • 7 Glasky AJ. Glasky MS. Ritzmann RF. Rathbone MP. Exp. Opin. Invest. Drugs  1997,  6:  1413 
  • 8 Rathbone MP. Middlemiss PJ. Crocker CE. Glasky MS. Juurlink BHJ. Ramirez JJ. Cicarelli R. Di Ioro P. Caciagli F. Exp. Opin. Invest. Drugs  1999,  8:  1255 
  • 9 Grundman M. Caparelli E. Kim HT. Morris JC. Farlow M. Rubin EH. Heidebrink J. Hake A. Ho G. Schultz AN. Schafer K. Houston W. Thomas R. Thal LJ. Life Sci.  2003,  73:  539 
  • 10 Holmes M. Maysinger D. Foerster D. Pertens E. Barlas C. Diamond J. Mol. Cell. Neurosci.  2003,  24:  568 
  • 11 Glasky AJ. inventors; PCT Int. Appl. WO  9957119.  Chem. Abstr. 1999, 131, 322486
  • 12a Zhang H.-C. Brakta M. Daves GD. Tetrahedron Lett.  1993,  34:  1571 
  • 12b Zhang H.-C. Daves GD. Organometallics  1993,  12:  1499 
  • 12c Zhang H.-C. Brakta M. Daves GD. Nucleosides Nucleotides  1995,  14:  105 
  • 13 Raboisson P. Baurand A. Cazenave J.-P. Gachet C. Schultz D. Spiess B. Bourguignon J.-J. J. Org. Chem.  2002,  67:  8063 
  • 14a Kobe J. Robins RK. O’Brien DE. J. Heterocycl. Chem.  1974,  199 
  • 14b Tam SY.-K. Klein RS. Wempen I. Fox JJ. J. Org. Chem.  1979,  44:  4547 
  • 14c Vogel A. Troxler F. Helv. Chim. Acta  1975,  58:  761 
  • 15a Raboisson P. Schultz D. Lugnier C. Bourguignon J.-J. Tetrahedron Lett.  2002,  43:  9501 
  • 15b Raboisson P. Schultz D. Lugnier C. Mathieu R. Bourguignon J.-J. Tetrahedron Lett.  2003,  44:  703 
  • 16 Liu Y. Li K. Macromol. Rapid Commun.  2002,  23:  739 
  • 17 Bernard P, Raboisson P, and Joseph B. inventors; PCT Int. Appl. WO  2004011464.  Chem. Abstr. 2004, 140, 146171